We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
-3.16%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$311M
AUM Growth
-$32.2M
Cap. Flow
-$12.3M
Cap. Flow %
-3.96%
Top 10 Hldgs %
68.12%
Holding
42
New
1
Increased
1
Reduced
20
Closed
1

Top Buys

Rank Stock Value
1
AER icon
AerCap
AER
+$6.71M
2
LLY icon
Eli Lilly
LLY
+$1.66M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$4.75M
2
UHAL.B icon
U-Haul Holding Co Series N
UHAL.B
+$2.67M
3
BHC icon
Bausch Health
BHC
+$2.3M
4
DAR icon
Darling Ingredients
DAR
+$2.27M
5
ABBV icon
AbbVie
ABBV
+$1.65M

Sector Composition

Rank Sector Weight
1 Healthcare 27.71%
2 Utilities 26.85%
3 Industrials 18.83%
4 Financials 9.16%
5 Communication Services 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNL icon
26
Personalis
PSNL
$1.61B
$1.46M 0.47%
253,000
-47,000
-16% -$217K
BHC icon
27
Bausch Health
BHC
$1.8B
$1.38M 0.44%
171,000
-279,000
-62% -$2.3M
SIRI icon
28
SiriusXM
SIRI
$10.3B
$1.27M 0.41%
55,784
– –
MNKD icon
29
MannKind Corp
MNKD
$1.25B
$1.25M 0.4%
195,073
– –
FOCL
30
EDAP TMS S.A.
FOCL
$204M
$1.22M 0.39%
553,652
– –
ASH icon
31
Ashland
ASH
$3.14B
$1.07M 0.34%
15,000
– –
LVTX
32
DELISTED
LAVA Therapeutics
LVTX
$733K 0.24%
771,874
– –
VTRS icon
33
Viatris
VTRS
$20.1B
$726K 0.23%
58,279
-554
-0.9% -$6.81K
IGMS
34
DELISTED
IGM Biosciences
IGMS
$611K 0.2%
100,000
– –
FATE icon
35
Fate Therapeutics
FATE
$324M
$578K 0.19%
350,000
– –
OGN icon
36
Organon & Co
OGN
$3.55B
$466K 0.15%
31,200
-170
-0.5% -$2.77K
CRBU icon
37
Caribou Biosciences
CRBU
$164M
$398K 0.13%
250,000
-50,000
-17% -$101K
WEC icon
38
WEC Energy
WEC
$36.9B
$371K 0.12%
3,945
-564
-13% -$54.7K
MASS icon
39
908 Devices
MASS
$302M
$150K 0.05%
68,286
– –
WBD icon
40
Warner Bros
WBD
$67.4B
– –
-11,851
Closed -$97.8K
1
2

Similar funds

RFS
Retirement Financial Solutions Knoxville, Tennessee $350M AUM 16.94% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $349M AUM 20.19% 1-Year Est. Return
SA
SRH Advisors Salina, Kansas $349M AUM 10.46% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Bruce & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Bruce & Co held 42 positions worth $311M, down 9.4% from $344M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Bruce & Co withdrew a net $12.3M in Q4 2024, closing 1 position and reducing 20 holdings. Its most notable exit was Warner Bros, an estimated $97.8K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Eli Lilly worth $1.54M.

  • Bruce & Co's largest Q4 2024 buy was Eli Lilly: 2,000 shares worth $1.54M.
  • Bruce & Co added most to AerCap in Q4 2024, an estimated $6.71M increase.
  • Bruce & Co's biggest Q4 2024 reduction was AT&T, cutting an estimated $4.75M.
  • Bruce & Co fully exited Warner Bros in Q4 2024, selling an estimated $97.8K.
  • Bruce & Co's ten largest holdings make up 68% of its $311M portfolio in Q4 2024.
  • Bruce & Co opened 1 new position and closed 1 in Q4 2024.
  • Bruce & Co's portfolio value fell 9.4% quarter-over-quarter to $311M.

Based on Bruce & Co's 13F filing for Q4 2024, filed 11 Feb 2025.